BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 23609760)

  • 1. Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa.
    Yang QZ; Wang C; Lang L; Zhou Y; Wang H; Shang DJ
    Arch Pharm Res; 2013 Nov; 36(11):1302-10. PubMed ID: 23609760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects and cell selectivity of temporin-1CEa, an antimicrobial peptide from the skin secretions of the Chinese brown frog (Rana chensinensis).
    Wang C; Li HB; Li S; Tian LL; Shang DJ
    Biochimie; 2012 Feb; 94(2):434-41. PubMed ID: 21871946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer mechanisms of temporin-1CEa, an amphipathic α-helical antimicrobial peptide, in Bcap-37 human breast cancer cells.
    Wang C; Zhou Y; Li S; Li H; Tian L; Wang H; Shang D
    Life Sci; 2013 May; 92(20-21):1004-14. PubMed ID: 23583573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.
    Conlon JM; Galadari S; Raza H; Condamine E
    Chem Biol Drug Des; 2008 Jul; 72(1):58-64. PubMed ID: 18554256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for transformation of naturally-occurring amphibian antimicrobial peptides into therapeutically valuable anti-infective agents.
    Conlon JM; Al-Ghaferi N; Abraham B; Leprince J
    Methods; 2007 Aug; 42(4):349-57. PubMed ID: 17560323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma cell surface-expressed phosphatidylserine as a therapeutic target for cationic anticancer peptide, temporin-1CEa.
    Wang C; Chen YW; Zhang L; Gong XG; Zhou Y; Shang DJ
    J Drug Target; 2016; 24(6):548-56. PubMed ID: 26596643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cloning of cDNAs encoding skin antimicrobial peptide precursors from Chinese brown frogs, Rana chensinensis and determination of antimicrobial, anticancer and hemolysis activity].
    Yu F; Zhang L; Li J; Li X; Fu X; Shang D
    Sheng Wu Gong Cheng Xue Bao; 2009 Jan; 25(1):101-8. PubMed ID: 19441234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent.
    Conlon JM; Mechkarska M; Prajeep M; Arafat K; Zaric M; Lukic ML; Attoub S
    Amino Acids; 2013 Feb; 44(2):715-23. PubMed ID: 22965637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship, conformational and biological studies of temporin L analogues.
    Mangoni ML; Carotenuto A; Auriemma L; Saviello MR; Campiglia P; Gomez-Monterrey I; Malfi S; Marcellini L; Barra D; Novellino E; Grieco P
    J Med Chem; 2011 Mar; 54(5):1298-307. PubMed ID: 21319749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, pseudin-2.
    Pál T; Sonnevend A; Galadari S; Conlon JM
    Regul Pept; 2005 Jul; 129(1-3):85-91. PubMed ID: 15927702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-tumor activities of the host-defense peptide hymenochirin-1B.
    Attoub S; Arafat H; Mechkarska M; Conlon JM
    Regul Pept; 2013 Nov; 187():51-6. PubMed ID: 24185042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of imperfectly amphipathic α-helical antimicrobial peptides with enhanced cell selectivity.
    Zhu X; Dong N; Wang Z; Ma Z; Zhang L; Ma Q; Shan A
    Acta Biomater; 2014 Jan; 10(1):244-57. PubMed ID: 24021230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designed synthetic analogs of the α-helical peptide temporin-La with improved antitumor efficacies via charge modification and incorporation of the integrin αvβ3 homing domain.
    Diao Y; Han W; Zhao H; Zhu S; Liu X; Feng X; Gu J; Yao C; Liu S; Sun C; Pan F
    J Pept Sci; 2012 Jul; 18(7):476-86. PubMed ID: 22641352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic activities of the frog skin peptide, temporin-1DRa.
    Conlon JM; Al-Kharrge R; Ahmed E; Raza H; Galadari S; Condamine E
    Peptides; 2007 Oct; 28(10):2075-80. PubMed ID: 17767978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid cytotoxicity of antimicrobial peptide tempoprin-1CEa in breast cancer cells through membrane destruction and intracellular calcium mechanism.
    Wang C; Tian LL; Li S; Li HB; Zhou Y; Wang H; Yang QZ; Ma LJ; Shang DJ
    PLoS One; 2013; 8(4):e60462. PubMed ID: 23577112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of interactions between hydrophobic residues on nonpolar faces is a key determinant in decreasing hemolysis and increasing antimicrobial activities of α-helical amphipathic peptides.
    Son M; Lee Y; Hwang H; Hyun S; Yu J
    ChemMedChem; 2013 Oct; 8(10):1638-42. PubMed ID: 23894079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of potent, non-toxic antimicrobial agents based upon the structure of the frog skin peptide, temporin-1CEb from Chinese brown frog, Rana chensinensis.
    Shang D; Li X; Sun Y; Wang C; Sun L; Wei S; Gou M
    Chem Biol Drug Des; 2012 May; 79(5):653-62. PubMed ID: 22348663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective cytotoxicity of the antibacterial peptide ABP-dHC-Cecropin A and its analog towards leukemia cells.
    Sang M; Zhang J; Zhuge Q
    Eur J Pharmacol; 2017 May; 803():138-147. PubMed ID: 28347740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial and cytolytic properties of the frog skin peptide, kassinatuerin-1 and its L- and D-lysine-substituted derivatives.
    Conlon JM; Abraham B; Galadari S; Knoop FC; Sonnevend A; Pál T
    Peptides; 2005 Nov; 26(11):2104-10. PubMed ID: 15885852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa.
    Mechkarska M; Attoub S; Sulaiman S; Pantic J; Lukic ML; Conlon JM
    Regul Pept; 2014 Nov; 194-195():69-76. PubMed ID: 25447194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.